JP2024150674A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2024150674A5 JP2024150674A5 JP2024119250A JP2024119250A JP2024150674A5 JP 2024150674 A5 JP2024150674 A5 JP 2024150674A5 JP 2024119250 A JP2024119250 A JP 2024119250A JP 2024119250 A JP2024119250 A JP 2024119250A JP 2024150674 A5 JP2024150674 A5 JP 2024150674A5
- Authority
- JP
- Japan
- Prior art keywords
- amino acid
- variable region
- seq
- acid sequence
- heavy chain
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2026018549A JP2026086616A (ja) | 2018-08-22 | 2026-02-06 | 抗her2ポリペプチド及びそれらの使用の方法 |
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862721505P | 2018-08-22 | 2018-08-22 | |
| US62/721,505 | 2018-08-22 | ||
| JP2021510094A JP2021534220A (ja) | 2018-08-22 | 2019-08-22 | 抗her2ポリペプチド及びそれらの使用の方法 |
| PCT/US2019/047728 WO2020041604A1 (en) | 2018-08-22 | 2019-08-22 | Anti-her2 polypeptides and methods of use thereof |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021510094A Division JP2021534220A (ja) | 2018-08-22 | 2019-08-22 | 抗her2ポリペプチド及びそれらの使用の方法 |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2026018549A Division JP2026086616A (ja) | 2018-08-22 | 2026-02-06 | 抗her2ポリペプチド及びそれらの使用の方法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2024150674A JP2024150674A (ja) | 2024-10-23 |
| JP2024150674A5 true JP2024150674A5 (cg-RX-API-DMAC7.html) | 2025-04-11 |
| JP7818042B2 JP7818042B2 (ja) | 2026-02-19 |
Family
ID=67989062
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021510094A Pending JP2021534220A (ja) | 2018-08-22 | 2019-08-22 | 抗her2ポリペプチド及びそれらの使用の方法 |
| JP2024119250A Active JP7818042B2 (ja) | 2018-08-22 | 2024-07-25 | 抗her2ポリペプチド及びそれらの使用の方法 |
| JP2026018549A Pending JP2026086616A (ja) | 2018-08-22 | 2026-02-06 | 抗her2ポリペプチド及びそれらの使用の方法 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021510094A Pending JP2021534220A (ja) | 2018-08-22 | 2019-08-22 | 抗her2ポリペプチド及びそれらの使用の方法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2026018549A Pending JP2026086616A (ja) | 2018-08-22 | 2026-02-06 | 抗her2ポリペプチド及びそれらの使用の方法 |
Country Status (15)
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RS63818B1 (sr) | 2017-02-17 | 2023-01-31 | Denali Therapeutics Inc | Konstruisani polipeptidi za vezivanje za receptor transferina |
| BR112020005271A2 (pt) | 2017-10-02 | 2020-09-15 | Denali Therapeutics Inc. | proteína, polipeptídeo, polinucleotídeo, vetor, célula hospedeira, método para produção de um polipeptídeo, métodos de tratamento de um distúrbio, de diminuição do acúmulo, de monitoramento, de transporte de um agente e de tratamento de um lsd e composição farmacêutica |
| JP7543290B2 (ja) | 2019-02-20 | 2024-09-02 | デナリ セラピューティクス インコーポレイテッド | 抗trem2抗体及びその使用方法 |
| BR112022012230A2 (pt) | 2019-12-23 | 2022-08-30 | Denali Therapeutics Inc | Variantes de progranulina |
| US11124567B2 (en) | 2020-01-13 | 2021-09-21 | Denali Therapeutics Inc. | Anti-TREM2 antibodies and methods of use thereof |
| CA3170338A1 (en) * | 2020-02-19 | 2021-08-26 | Denali Therapeutics Inc. | Engineered anti-her2 bispecific proteins |
| CR20230178A (es) | 2020-10-14 | 2023-07-26 | Denali Therapeutics Inc | Proteínas de fusión que comprenden enzimas sulfoglucosamina sulfohidrolasa y métodos de estas |
| IL311003A (en) | 2021-08-25 | 2024-04-01 | Denali Therapeutics Inc | Anti-2HER antibodies and methods of using them |
| US20240392035A1 (en) * | 2021-08-25 | 2024-11-28 | Denali Therapeutics Inc. | Engineered anti-her2 bispecific proteins |
| US20250066449A1 (en) * | 2021-12-31 | 2025-02-27 | Imnewrun, Inc. | Blood-brain barrier permeable fusion protein and uses thereof |
| KR20240067001A (ko) * | 2022-10-28 | 2024-05-16 | 주식회사 아임뉴런 | 뇌혈관장벽 투과성 융합 단백질 및 이의 용도 |
| JP2025540336A (ja) * | 2022-12-08 | 2025-12-11 | アデル,インク | 抗タウ抗体及びペプチドを含む融合体とその用途 |
| CN120648654A (zh) * | 2024-03-13 | 2025-09-16 | 深圳太力生物技术有限责任公司 | 重组细胞的制备方法、重组细胞及其应用 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE423140T1 (de) * | 2005-01-05 | 2009-03-15 | F Star Biotech Forsch & Entw | Synthetische immunoglobulindomänen mit in regionen des moleküls, die sich von den die komplementarität bestimmenden bereichen unterscheiden, modifizierten bindeeigenschaften |
| MX367126B (es) * | 2012-08-29 | 2019-08-06 | Hoffmann La Roche | Transporte para atravesar la barrera hematoencefálica. |
| WO2014089209A2 (en) * | 2012-12-04 | 2014-06-12 | Abbvie, Inc. | Blood-brain barrier (bbb) penetrating dual specific binding proteins |
| WO2015191934A2 (en) * | 2014-06-11 | 2015-12-17 | Abbvie Inc. | Blood-brain barrier (bbb) penetrating dual specific binding proteins for treating brain and neurological diseases |
| JP7021955B2 (ja) * | 2015-06-24 | 2022-03-03 | エフ・ホフマン-ラ・ロシュ・アクチェンゲゼルシャフト | Her2及び血液脳関門受容体に特異的な三重特異性抗体及び使用方法 |
| CN107446045A (zh) * | 2016-07-22 | 2017-12-08 | 北京天广实生物技术股份有限公司 | 一种抗her2的抗体、其药物组合物及用途 |
| RS63818B1 (sr) * | 2017-02-17 | 2023-01-31 | Denali Therapeutics Inc | Konstruisani polipeptidi za vezivanje za receptor transferina |
| CA3053379A1 (en) * | 2017-02-17 | 2018-08-23 | Denali Therapeutics Inc. | Anti-tau antibodies and methods of use thereof |
| WO2019032955A1 (en) * | 2017-08-10 | 2019-02-14 | Denali Therapeutics Inc. | MODIFIED TRANSFERRIN RECEPTOR BINDING POLYPEPTIDES |
-
2019
- 2019-08-22 EP EP19769934.1A patent/EP3840781A1/en active Pending
- 2019-08-22 CN CN201980068845.5A patent/CN113286610A/zh active Pending
- 2019-08-22 WO PCT/US2019/047728 patent/WO2020041604A1/en not_active Ceased
- 2019-08-22 TW TW108130121A patent/TW202017947A/zh unknown
- 2019-08-22 AR ARP190102390A patent/AR115998A1/es unknown
- 2019-08-22 MX MX2021001976A patent/MX2021001976A/es unknown
- 2019-08-22 AU AU2019326545A patent/AU2019326545A1/en not_active Abandoned
- 2019-08-22 IL IL326298A patent/IL326298A/en unknown
- 2019-08-22 KR KR1020217008163A patent/KR20210074279A/ko not_active Ceased
- 2019-08-22 CA CA3141815A patent/CA3141815A1/en active Pending
- 2019-08-22 SG SG11202101436SA patent/SG11202101436SA/en unknown
- 2019-08-22 EA EA202190603A patent/EA202190603A1/ru unknown
- 2019-08-22 BR BR112021002953-2A patent/BR112021002953A2/pt unknown
- 2019-08-22 JP JP2021510094A patent/JP2021534220A/ja active Pending
-
2021
- 2021-02-16 IL IL280922A patent/IL280922B2/en unknown
- 2021-02-18 US US17/178,595 patent/US20220002436A1/en active Pending
-
2024
- 2024-07-25 JP JP2024119250A patent/JP7818042B2/ja active Active
-
2026
- 2026-01-07 AU AU2026200081A patent/AU2026200081A1/en active Pending
- 2026-02-06 JP JP2026018549A patent/JP2026086616A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2021534220A5 (cg-RX-API-DMAC7.html) | ||
| JP2021533779A5 (cg-RX-API-DMAC7.html) | ||
| US11325982B2 (en) | Biparatopic and multiparatopic antibodies with common light chain and method of use | |
| JP2020196744A5 (cg-RX-API-DMAC7.html) | ||
| US8871912B2 (en) | Engineered heterodimeric protein domains | |
| JP2022551969A5 (cg-RX-API-DMAC7.html) | ||
| RU2015145719A (ru) | Модифицированные асимметричные антитела, связывающие fc-рецептор, и способы их применения | |
| CN106164095A (zh) | 多特异性抗体 | |
| AU2018387829B2 (en) | Bispecific antigen binding construct | |
| JP2021521781A5 (cg-RX-API-DMAC7.html) | ||
| US20230192887A1 (en) | Engineered anti-her2 bispecific proteins | |
| US20220119549A1 (en) | Shielded biologics with masking domains to shield antigen binding capability of biologics and uses thereof | |
| JP2022521305A (ja) | 抗pd-l1抗体及びその使用 | |
| JPWO2022102768A5 (cg-RX-API-DMAC7.html) | ||
| US12486321B2 (en) | Agents that interfere with IL-1BETA receptor signalling | |
| IL318098A (en) | IGE-FCER pushers | |
| CN119546637A (zh) | 与FCγ受体的结合降低的嵌合重链恒定结构域及其用途 | |
| CA3229542A1 (en) | Anti-her2 antibodies and methods of use thereof | |
| JP2024534118A5 (cg-RX-API-DMAC7.html) | ||
| JP2021510162A5 (cg-RX-API-DMAC7.html) | ||
| US20260055171A1 (en) | Vegf antagonists and methods of use thereof | |
| US20240287162A1 (en) | Multivalent anti-spike protein binding molecules and uses thereof | |
| US20240309072A1 (en) | Multivalent anti-spike protein binding molecules and uses thereof | |
| JP2025516631A5 (cg-RX-API-DMAC7.html) | ||
| JP2025511000A5 (cg-RX-API-DMAC7.html) |